Medical Cannabis

Products

Information

Key value points: GMP‑grade formulation engineeringControlled‑release cannabinoid technologiesStability‑optimized systems for THC (dronabinol), CBD, and minor cannabinoidsScalable development for clinical and commercial use OUR FORMULATION PLATFORM fOR MEDICAL CANNABISCannabinoid stability management: We support granulation and encapsulation platforms that prevent potency loss and ensures shelf‑life integrity.Bioavailability optimization: re-emulsifying drug delivery systems (REDDS) technologies, granulation or protective layering can improve absorption or oral bioavailability.Precision in controlled drug release: serving the right drug dose at the right time: Immediate, Extended, Sustained, Multi‑phase release profilesCompatible with multiple dosage forms:GranulesPelletsOilsCapsules

Product Categories

Pharmaceutical Machinery & Technology
- Drug Formulation (general category)

Distribution Areas

OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)

Supplied From

Germany

Glatt GroupThe Glatt Group has been involved in powder technology for over 70 years and has become renowned as one of the world's major manufacturers in fluid beds for the pharmaceutical industries, specialising in techniques for solid product forms for the food, feed, pharmaceutical and fine chemical industries.Besides pilot and production equipment for both batch and continuous processing Glatt has further extended to a wide range of processing lines, offering product and process development, contract manufacturing, plant design and engineering services.

Medical Cannabis

Information

Log in